98HDC20935
| Complaint
The consumer complained to the Pharmaceutical Society of New Zealand about services provided to him by the pharmacy. The Pharmaceutical Society forwarded the complaint to the Commissioner. The details of the complaint are:
|
|
The complaint was received by the Commissioner on 16 November 1998 and an investigation was undertaken. As the investigation progressed the Commissioner became aware that the pharmacist had dispensed the medication and the investigation was extended to include him. Information was obtained from: The Consumer/Complainant Copies of relevant medical records were obtained from the consumer's general practitioner. A copy of the prescription form was obtained from Health Benefits Limited. |
|
On or about mid-May 1998 the consumer went to the pharmacy to collect a prescription for plendil blood pressure tablets. A box of tablets was dispensed to the consumer and he returned home. The pharmacist has confirmed that he dispensed the consumer's medication on this occasion. The consumer later took one of the tablets and started to feel unwell. He advises that his heart started pounding, he developed a headache and he became dizzy. When he checked the box of tablets he discovered that the pills were labeled imdur rather than plendil. The consumer did not take any further tablets. The consumer advised the Commissioner that the day after he took the imdur tablet he consulted his doctor. Medical notes obtained from the consumer's general practitioner recorded:
The consumer advised the Commissioner that he and his wife later returned to the pharmacy and complained to the governing director of the pharmacy. The date of this visit is not known. The governing director apologised to the consumer for the error and advised that the prescription had been prepared by another staff member. The consumer returned the remaining imdur tablets and the director provided the correct medication for the consumer. The consumer advised that during this visit he was not informed of his right to complain to the Commissioner about the services that he had received and the mistake that had been made. The director advised the Commissioner that the staff member who had dispensed the medication to the consumer was the pharmacist. The pharmacist ceased working for the director in September 1998 and is currently practising in another country. The director advised that there were no written dispensing or checking policies in place at the pharmacy at the time that this incident occurred in May 1998. The director advised that before new policies were introduced in early April 1999 he expected his employees to dispense medication correctly and he noted that dispensing and checking techniques were taught during pharmacy training. The director advised that when two pharmacists are on duty they cross check each other's work. When only one pharmacist is working he or she should self check the prescriptions. At the time the incident occurred the pharmacist was in sole charge of the pharmacy. The pharmacist confirmed to the Commissioner that he was the pharmacist who had dispensed the medication to the consumer. The pharmacist also confirmed that he had mistakenly dispensed imdur instead of plendil tablets. The pharmacist advised me that he believed the mistake occurred because the imdur tablet boxes had been mistakenly placed in the position where the plendil boxes were usually kept. The imdur boxes were a similar size to the plendil packets. During the course of the investigation the person responsible for placing the imdur boxes in the wrong position on the dispensary shelf was not identified. In response to the suggestion that the consumer was not satisfied with the pharmacy's response to his complaint the director advised the Commissioner that when he was informed of the mistake he apologised to the consumer and speedily rectified the problem. He noted that the consumer continued to have his medication supplied by the pharmacy after the incident occurred. The director stated that he regarded the error very seriously and all his efforts were spent trying to avoid this type of situation. The pharmacy did not have a written complaints policy in place during 1998. A copy of the relevant prescription was requested from Health Benefits Limited. A prescription for plendil dated early April 1998 was obtained and details of a repeat prescription dispensed in early June 1998 were viewed. Health Benefits Limited were not able to provide details about any plendil tablets dispensed to the consumer during May 1998. Plendil is used to treat high blood pressure while imdur is used for the treatment of angina and chest pain. The adverse effects of imdur can include headache, nausea and dizziness, and increased heart rate. |
|
?BR>6) Every provider, unless an employee of a provider, must have a complaints procedure that ensures that - a) The complaint is acknowledged in writing within 5 working days of receipt, unless it has been resolved to the satisfaction of the consumer within that period; and b) The consumer is informed of any relevant internal and external complaints procedures, including the availability of - i. Independent advocates provided under the Health and Disability Commissioner Act 1994; and ii. The Health and Disability Commissioner; ?/I> |
|
Pharmaceutical Society of New Zealand Code of Ethics Rule 2.1 states: A pharmacist must safeguard the interest of the public in the supply of health and medicinal products. Rule 2.11 states in part: A pharmacist must be responsible for maintaining and supervising a disciplined dispensing procedure that ensures a high standard is achieved? Rule 2.28 states: A pharmacist must ensure that a documented procedure is followed for handling complaints so that a satisfactory resolution is reached. Consumers must be informed as to where they can further complain if a satisfactory resolution is not reached and of their rights under the Code of Rights for Consumers of Health and Disability Services. Quality Standards for Pharmacy in New Zealand Standard 6.2 states: The pharmacist maintains a disciplined dispensing procedure which ensures that the appropriate product is selected and dispensed correctly and efficiently. Standard 6.2(a) states: Procedures for dispensing and supply of pharmaceuticals are developed, documented and approved by the pharmacist. |
|
Right 4(2) |
|
In my opinion the pharmacy breached Right 4(2) and Right 10(6) as follows: Right 4(2) Right 10(6) |
|
I recommend that:.
|
|
I recommend that:
A copy of this opinion will be forwarded to the Pharmaceutical Society of New Zealand. A copy will also be sent to the Pharmacy Board of the country in which the pharmacist is currently practising. For further information, contact: HDC Communications Section (09) 373 1060. Or by email: your.rights@xtra.co.nz |
